+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Autologous Cell Therapies Market by Therapy Area (Dermatology, Immunology, Neurology), Cell Type (Dendritic Cells, Nk Cells, Stem Cells), Source Tissue, Process Technology, End User - Global Forecast 2025-2030- Product Image
Autologous Cell Therapies Market by Therapy Area (Dermatology, Immunology, Neurology), Cell Type (Dendritic Cells, Nk Cells, Stem Cells), Source Tissue, Process Technology, End User - Global Forecast 2025-2030- Product Image
Sale

Autologous Cell Therapies Market by Therapy Area (Dermatology, Immunology, Neurology), Cell Type (Dendritic Cells, Nk Cells, Stem Cells), Source Tissue, Process Technology, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887813
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The autologous cell therapies market is rapidly transforming the landscape of personalized medicine, integrating biotechnological innovation and patient-centric approaches to enable more precise, effective care tailored to individual clinical needs.

Market Snapshot: Autologous Cell Therapies Market

The Autologous Cell Therapies Market grew from USD 9.24 billion in 2024 to USD 10.62 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.63%, and is projected to reach USD 20.99 billion by 2030. This growth highlights surging demand for patient-specific treatments across multiple therapy areas, driven by advancements in process automation, cell reprogramming, and regulatory frameworks fostering commercialization. The sector is witnessing substantial investment and attention as healthcare providers and payers seek solutions promising improved clinical outcomes and operational efficiencies.

Scope & Segmentation

This report provides in-depth coverage and analysis of the autologous cell therapies sector across the following dimensions:

  • Therapy Areas: Dermatology (wound healing); Immunology (autoimmune, transplant rejection); Neurology (Parkinson’s, spinal cord injury); Oncology (hematological cancers, solid tumors); Orthopedics (bone regeneration, cartilage repair).
  • Cell Types: Dendritic cells; Natural killer cells (including CAR NK); Stem cells (hematopoietic, induced pluripotent, mesenchymal); T cells (CAR T, TCR T).
  • Source Tissues: Adipose tissue; Bone marrow; Cord blood; Peripheral blood.
  • Process Technologies: Expansion systems; Formulation methods (cryopreservation, lyophilization); Genetic modification (non-viral, viral vector); Isolation protocols.
  • End Users: Contract manufacturing organizations; Hospitals (academic and community); Research institutes; Specialty clinics.
  • Regions Covered: Americas (including the US, Brazil, Canada, Mexico, Argentina); Europe, Middle East & Africa (including the UK, Germany, France, Italy, Saudi Arabia, South Africa, among others); Asia-Pacific (including China, India, Japan, Australia, South Korea, Singapore, Vietnam, and others).
  • Leading Companies Assessed: Novartis AG, Gilead Sciences, Bristol-Myers Squibb, bluebird bio, Legend Biotech, Autolus Therapeutics, Adaptimmune Therapeutics, MaxCyte, Celyad Oncology, Poseida Therapeutics.

Key Takeaways for Senior Decision-Makers

  • Personalized therapies are reshaping disease management paradigms, especially where conventional approaches offer limited benefit.
  • Progress in cell processing, genomic editing, and integrated manufacturing platforms is increasing efficiency and enabling wider patient access.
  • Adoption of adaptive regulatory frameworks is speeding up the pathway from clinical trials to market, yet manufacturers must remain agile to stay compliant.
  • Strategic partnerships between biopharma, technology innovators, and contract service providers are facilitating co-development and commercialization of advanced cell therapies.
  • The ecosystem encompasses a diverse end-user profile, requiring tailored market entry and engagement strategies for contract manufacturers, research institutions, and specialty clinics.
  • Regional variations, including government support in Asia-Pacific and regulatory harmonization in Europe, shape both opportunity and go-to-market considerations for global players.

Tariff Impact: Navigating U.S. Changes in 2025

Upcoming United States tariff modifications will alter procurement costs for reagents, vectors, and bioprocessing equipment, potentially compressing manufacturer margins. Industry players are responding with strategies such as supplier diversification, leveraging free trade zones, and adopting regionalized manufacturing models to bolster supply chain resilience and manage volatility. These actions aim to support clinical development continuity and maintain market accessibility despite cost headwinds.

Methodology & Data Sources

Findings are grounded in a multi-layered approach: primary research through structured interviews with senior stakeholders, triangulated with survey results, and secondary research based on peer-reviewed literature, regulatory guidelines, patent filings, and clinical trial registries. Rigorous quality checks and expert panel validations ensure data reliability and actionable insights.

Why This Report Matters

  • Strategic, evidence-based recommendations empower decision-makers to anticipate regulatory, technological, and commercial challenges in autologous cell therapy deployment.
  • Detailed market segmentation and regional intelligence provide a clear roadmap for targeting high-growth segments and optimizing resource allocation.
  • Focused insight into evolving partnerships, ecosystem dynamics, and best practices guides leaders towards sustainable growth and risk mitigation.

Conclusion

Autologous cell therapies are at the convergence of biotechnology and individualized care, with market forces and technological advances setting the pace for transformation. Informed leadership and sustained collaboration across the value chain will be essential to unlock continued progress and impact.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of decentralized, point-of-care automated manufacturing platforms for autologous cell therapies
5.2. Integration of AI-driven quality control and process optimization in autologous cell production workflows
5.3. Emerging gene editing modalities enhancing specificity and efficacy of autologous CAR-T and TCR therapies
5.4. Strategic partnerships between academic medical centers and biotechs to accelerate personalized cell therapy pipelines
5.5. Advancements in long-term cryopreservation solutions improving viability and shelf life of autologous cell products
5.6. Regulatory harmonization initiatives facilitating cross-border clinical trials and commercialization of autologous treatments
5.7. Reimbursement framework evolution including value-based contracts to support cost-intensive personalized cell therapies
5.8. Expansion of autologous cell therapy indications into regenerative orthopedics and neurology beyond oncology focus
5.9. Implementation of digital twin modeling for real-time monitoring and predictive maintenance of autologous manufacturing processes
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Autologous Cell Therapies Market, by Therapy Area
8.1. Introduction
8.2. Dermatology
8.2.1. Wound Healing
8.3. Immunology
8.3.1. Autoimmune Diseases
8.3.2. Transplant Rejection
8.4. Neurology
8.4.1. Parkinsons Disease
8.4.2. Spinal Cord Injury
8.5. Oncology
8.5.1. Hematological Cancer
8.5.2. Solid Tumors
8.6. Orthopedics
8.6.1. Bone Regeneration
8.6.2. Cartilage Repair
9. Autologous Cell Therapies Market, by Cell Type
9.1. Introduction
9.2. Dendritic Cells
9.3. Nk Cells
9.3.1. Car Nk
9.4. Stem Cells
9.4.1. Hematopoietic Stem
9.4.2. Ipsc
9.4.3. Mesenchymal Stem
9.5. T Cells
9.5.1. Car T
9.5.2. Tcr T
10. Autologous Cell Therapies Market, by Source Tissue
10.1. Introduction
10.2. Adipose Tissue
10.3. Bone Marrow
10.4. Cord Blood
10.5. Peripheral Blood
11. Autologous Cell Therapies Market, by Process Technology
11.1. Introduction
11.2. Expansion
11.3. Formulation
11.3.1. Cryopreservation
11.3.2. Lyophilization
11.4. Genetic Modification
11.4.1. Non-Viral
11.4.2. Viral Vector
11.5. Isolation
12. Autologous Cell Therapies Market, by End User
12.1. Introduction
12.2. Contract Manufacturing Org
12.3. Hospitals
12.3.1. Academic Medical Center
12.3.2. Community Hospital
12.4. Research Institutes
12.5. Specialty Clinics
13. Americas Autologous Cell Therapies Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Autologous Cell Therapies Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Autologous Cell Therapies Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Novartis AG
16.3.2. Gilead Sciences, Inc.
16.3.3. Bristol-Myers Squibb Company
16.3.4. bluebird bio, Inc.
16.3.5. Legend Biotech Corporation
16.3.6. Autolus Therapeutics plc
16.3.7. Adaptimmune Therapeutics plc
16.3.8. MaxCyte, Inc.
16.3.9. Celyad Oncology SA
16.3.10. Poseida Therapeutics, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. AUTOLOGOUS CELL THERAPIES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AUTOLOGOUS CELL THERAPIES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. AUTOLOGOUS CELL THERAPIES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. AUTOLOGOUS CELL THERAPIES MARKET: RESEARCHAI
FIGURE 26. AUTOLOGOUS CELL THERAPIES MARKET: RESEARCHSTATISTICS
FIGURE 27. AUTOLOGOUS CELL THERAPIES MARKET: RESEARCHCONTACTS
FIGURE 28. AUTOLOGOUS CELL THERAPIES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AUTOLOGOUS CELL THERAPIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY WOUND HEALING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY TRANSPLANT REJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY TRANSPLANT REJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PARKINSONS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PARKINSONS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SPINAL CORD INJURY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SPINAL CORD INJURY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HEMATOLOGICAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HEMATOLOGICAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY BONE REGENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DENDRITIC CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DENDRITIC CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CAR NK, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CAR NK, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HEMATOPOIETIC STEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HEMATOPOIETIC STEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IPSC, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IPSC, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY MESENCHYMAL STEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY MESENCHYMAL STEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CAR T, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CAR T, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY TCR T, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY TCR T, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY BONE MARROW, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CORD BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CORD BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY EXPANSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY EXPANSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY LYOPHILIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY LYOPHILIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NON-VIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NON-VIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ISOLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ISOLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CONTRACT MANUFACTURING ORG, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CONTRACT MANUFACTURING ORG, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ACADEMIC MEDICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ACADEMIC MEDICAL CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COMMUNITY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COMMUNITY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 193. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2024 (USD MILLION)
TABLE 194. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2025-2030 (USD MILLION)
TABLE 195. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, 2018-2024 (USD MILLION)
TABLE 196. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, 2025-2030 (USD MILLION)
TABLE 197. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 200. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 201. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 202. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 203. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 204. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 205. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 206. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 207. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, 2018-2024 (USD MILLION)
TABLE 208. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, 2025-2030 (USD MILLION)
TABLE 209. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 210. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 211. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 212. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 213. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2024 (USD MILLION)
TABLE 214. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2025-2030 (USD MILLION)
TABLE 215. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 216. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 217. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 218. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 219. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2024 (USD MILLION)
TABLE 220. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2025-2030 (USD MILLION)
TABLE 221. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 224. CANADA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 225. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2024 (USD MILLION)
TABLE 226. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2025-2030 (USD MILLION)
TABLE 227. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, 2018-2024 (USD MILLION)
TABLE 228. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, 2025-2030 (USD MILLION)
TABLE 229. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
TABLE 230. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
TABLE 231. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 232. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 233. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 234. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 235. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 236. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 237. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 238. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 239. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, 2018-2024 (USD MILLION)
TABLE 240. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, 2025-2030 (USD MILLION)
TABLE 241. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 242. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 243. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 244. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 245. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2024 (USD MILLION)
TABLE 246. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2025-2030 (USD MILLION)
TABLE 247. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 250. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 251. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2024 (USD MILLION)
TABLE 252. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2025-2030 (USD MILLION)
TABLE 253. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 256. MEXICO AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY NK CELLS, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY T CELLS, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY SOURCE TISSUE, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY PROCESS TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY GENETIC MODIFICATION, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY THERAPY AREA, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS CELL THERAPIES MARKET SIZE, BY DERMATOLOGY, 2025-2030 (USD MILLION)
TA

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Autologous Cell Therapies market report include:
  • Novartis AG
  • Gilead Sciences, Inc.
  • Bristol-Myers Squibb Company
  • bluebird bio, Inc.
  • Legend Biotech Corporation
  • Autolus Therapeutics plc
  • Adaptimmune Therapeutics plc
  • MaxCyte, Inc.
  • Celyad Oncology SA
  • Poseida Therapeutics, Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 10.62 Billion
Forecasted Market Value ( USD ) by 2030 $ 20.99 Billion
Compound Annual Growth Rate14.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Autologous Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type, By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Autologous Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type, By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 110 Pages
  • Global
From
Autologous CAR-T Cell Therapy Market by Indication (Leukemia, Multiple Myeloma, Non-Hodgkin Lymphoma), Cell Target Antigen (Bcma, Cd19), Therapy Line, End User - Global Forecast 2025-2030 - Product Image

Autologous CAR-T Cell Therapy Market by Indication (Leukemia, Multiple Myeloma, Non-Hodgkin Lymphoma), Cell Target Antigen (Bcma, Cd19), Therapy Line, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Autologous Cell Therapy Market Report and Forecast 2025-2034 - Product Image

Autologous Cell Therapy Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Cell Therapy Biomanufacturing Market by Manufacturing Model (Allogeneic, Autologous), Therapy Area (Autoimmune, Cardiovascular, Neurological), End User, Process Stage, Cell Type - Global Forecast 2025-2030 - Product Image

Cell Therapy Biomanufacturing Market by Manufacturing Model (Allogeneic, Autologous), Therapy Area (Autoimmune, Cardiovascular, Neurological), End User, Process Stage, Cell Type - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Cell Therapy - Global Strategic Business Report - Product Image

Cell Therapy - Global Strategic Business Report

  • Report
  • 263 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.